N/A N=50 Randomized Single-blind Health Services Research

Telehealth After Stroke Care: Integrated Multidisciplinary Access to Post-stroke Care

Stroke · Health Care Acceptability · Hypertension

Bottom Line

View on ClinicalTrials.gov: NCT04640519 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2022

Primary outcome: Primary: Percentage of Participants With Systolic BP Control — 76; 25 percentage of participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Usual care (Other); TASC intervention (Other)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Columbia University
Primary completion: Jul 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participants With Systolic BP Control	76; 25	—
PRIMARY Percentage of Participants Who Completed at Least 1 Video Visit	91; 75	—
SECONDARY Medication Adherence Percentage	67; 63	—

Summary

The Telehealth After Stroke Care (TASC) trial is a pilot randomized controlled trial. It aims to evaluate the feasibility of a telehealth based model providing multidisciplinary access including nursing, pharmacy and physician care, and obtain preliminary evidence of efficacy of an integrated telehealth approach to blood pressure management after stroke.

Eligibility Criteria

Inclusion Criteria

Presence of hypertension (by clinical history or hospital BP ≥140/90 on two occasions)
Plan for discharge home after stroke
Ability to provide consent (patient or caregiver)

Exclusion Criteria

Modified Rankin scale ≥ 4 at time of enrollment (severely disabled)
Pregnancy
Severe psychiatric illness
Dialysis or diagnosis of end stage renal disease
Life expectancy < 1 year or terminal illness
Symptomatic flow limiting cerebrovascular stenosis without plan for intervention, or long-term BP goal ≥ 140/90

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04640519). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.